CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Cash from Investing (Quarterly): -42.11M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -42.11M |
| September 30, 2023 | 15.46M |
| June 30, 2023 | 0.719M |
| March 31, 2023 | -60.64M |
| December 31, 2022 | 8.356M |
| September 30, 2022 | -4.549M |
| June 30, 2022 | 1.198M |
| March 31, 2022 | -50.99M |
| December 31, 2021 | -24.08M |
| September 30, 2021 | 28.29M |
| June 30, 2021 | 8.679M |
| March 31, 2021 | 35.69M |
| December 31, 2020 | -4.349M |
| September 30, 2020 | -41.33M |
| June 30, 2020 | 47.00M |
| March 31, 2020 | 46.63M |
| December 31, 2019 | 9.261M |
| September 30, 2019 | 38.51M |
| June 30, 2019 | -73.07M |
| March 31, 2019 | -9.044M |
| December 31, 2018 | 26.77M |
| September 30, 2018 | 11.61M |
| Date | Value |
|---|---|
| June 30, 2018 | -2.834M |
| March 31, 2018 | -89.66M |
| December 31, 2017 | 5.098M |
| September 30, 2017 | -71.90M |
| June 30, 2017 | 2.502M |
| March 31, 2017 | -3.224M |
| December 31, 2016 | 9.818M |
| September 30, 2016 | 0.395M |
| June 30, 2016 | -2.716M |
| March 31, 2016 | 19.63M |
| December 31, 2015 | 6.211M |
| September 30, 2015 | -24.95M |
| June 30, 2015 | 6.554M |
| March 31, 2015 | 1.099M |
| December 31, 2014 | 2.898M |
| September 30, 2014 | -10.78M |
| June 30, 2014 | -9.604M |
| March 31, 2014 | 0.55M |
| December 31, 2013 | -6.681M |
| September 30, 2013 | 0.30M |
| June 30, 2013 | 0.15M |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-73.07M
Minimum
Jun 2019
47.00M
Maximum
Jun 2020
-3.227M
Average
1.198M
Median
Jun 2022
Cash from Investing (Quarterly) Benchmarks
| Gilead Sciences Inc | -2.207B |
| Assure Holdings Corp | -0.112M |
| Societal CDMO Inc (DELISTED) | -0.734M |
| AN2 Therapeutics Inc | 0.42M |
| Madrigal Pharmaceuticals Inc | -362.12M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.38M |
| Cash from Financing (Quarterly) | 2.729M |
| Free Cash Flow | -72.98M |
| Free Cash Flow Per Share (Quarterly) | -0.2318 |
| Free Cash Flow to Equity (Quarterly) | -32.64M |
| Free Cash Flow Yield | -2.12% |